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bacteraemia with this pathogen to bowel disease. We also
summarize the characteristics of the previously described cases.
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E-mail: cenemchu@monteﬁore.orgIntroductionA 69-year-old Ecuadorian man with no known medical history
initially presented to the emergency department at the Einstein
Division of Monteﬁore Medical Center with complaints of
several days of headache and chills. At the time of evaluation,
the patient was afebrile (temperature 36.7°C), with a white
blood cell count of 9.9 g/L (normal range, 4.8–10.8 g/L). Bloodw Microbe and New Infect 2016; 13: 34–36
2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
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p://dx.doi.org/10.1016/j.nmni.2016.05.004and urine specimens were collected for culture, and the patient
was discharged home.
Five days after presentation to the emergency department,
Gram-negative bacilli were isolated from the anaerobic blood
culture bottle. The patient was telephoned and advised to re-
turn to the hospital for further evaluation.
At admission to the general medicine ward, the patient was
afebrile (temperature 36.7°C) with a white blood cell count
within the normal range, at 5.9 g/L. His previous headaches and
chills had spontaneously resolved, and hewas now asymptomatic.
He denied vomiting, abdominal pain, diarrhoea or constipation.
His physical examination revealed normal heart sounds, clear
lungs and a soft, nondistended and nontender abdomen. He un-
derwent computerized axial tomography of the abdomen and
pelvis without contrast. This revealed diverticulosis of the distal
descending and proximal sigmoid colon with minimal stranding
and no ﬂuid collection, consistent with mild diverticulitis. The
patient initially received one dose of ceftriaxone for Gram-
negative bacteraemia of unclear origin, but therapy was
changed to oral ciproﬂoxacin and metronidazole in light of the
radiologic ﬁndings, before ﬁnal identiﬁcation of B. virosa.Although
antibiotics do not hasten recovery or prevent relapses in un-
complicated diverticulitis, this patient’s documented bacter-
aemia, by deﬁnition, classiﬁed his condition as complicated
diverticulitis, for which antibiotics are advised [1].
TheGram-negative bacilli isolated in the anaerobic bottle were
identiﬁed as Butyricimonas virosa by matrix-assisted laser desorp-
tion/ionization time-of-ﬂight mass spectrometry (MALDI-TOF
MS) (Microﬂex MALDI Biotyper instrument, Bruker Daltonics,
Leipzig, Germany) by Real Time Classiﬁcation 3.1 software). The
isolate score (2.098) and consistency category (A)were indicative
of a reliable species level identiﬁcation. Antibiotic susceptibilities
were determined by Etest and demonstrated resistance to peni-
cillin G (minimum inhibitory concentration (MIC) >32) and cef-
triaxone (MIC >32.0). However, the organism was susceptible to
piperacillin/tazobactam (MIC0.125) andmetronidazole (MIC1.0).
The patient’s hospital course was brief and uneventful. He
was discharged to complete a 14-day course of oral antibiotics
as an outpatient. Colonoscopy was performed soon after
discharge, with the examination revealing several hyperplastic
polyps and a sessile serrated adenoma, all of which were
resected. However, there was no evidence of malignant colonic
neoplasm upon pathology evaluation.DiscussionAlthough generally uncommon, anaerobic organisms do
contribute to bloodstream infections, accounting for 0.5 to 12%iology and Infectious Diseases
nses/by-nc-nd/4.0/)
TABLE 1. Characteristics of three patients with Butyricimonas virosa bacteraemia
Age Gender
Reason for initial
presentation Clinical presentation
Diagnostic
Methods Susceptibilities Outcome
72 M Aortic aneurysm surgery
in patient with previously
diagnosed adenocarcinoma
of colon [3]
Fever 24 days after
surgery. Anaerobic
blood cultures with
Gram-negative bacilli.
16S rRNA gene
sequencing
Susceptible: amp,
ams, amc, tzp,
ipm, mem, cli, mtz
Septic shock and later death
due to infection with
another organism
81 M Whipple procedure
for adenocarcinoma
of duodenum [4]
Fever 18 days after Whipple
procedure. Anaerobic
blood cultures with
Gram-negative bacilli.
MALDI-TOF MS Resistant: kan, van, cst Recovered without antibiotic
therapy
69 M Headache and chills Headache and chills. Acute
complicated diverticulitis.
Anaerobic blood culture
bottles with Gram-negative
bacilli.
MALDI-TOF MS Resistant: pen, ctx.
Susceptible: tzp, mtz
Recovered before initiation of
oral antibiotic therapy
amc, amoxicillin/clavulanate; amp, ampicillin; ams, ampicillin/sulbactam; cli, clindamycin; cst, colistin; ctx, ceftriaxone; ipm, imipenem; kan, kanamycin; MALDI-TOF MS, matrix-
assisted laser desorption/ionization time-of-ﬂight mass spectrometry; mem, meropenem; mtz, metronidazole; pen, penicillin; tzp, piperacillin/tazobactam; van, vancomycin.
NMNI Enemchukwu et al. B. virosa bacteraemia 35of all positive blood cultures [2]. The most commonly isolated
organisms are of the Bacteroides fragilis group, Clostridium spp.,
and Peptostreptococcus spp. [2]. Anaerobic bacteraemia has been
most frequently associated with an abdominal source of infec-
tion, which accounts for about 50 to 70% of cases [2].
There are two other reported cases of human infection with
B. virosa. The ﬁrst case was described by Toprak et al. [3] in a 72-
year-old man with previously diagnosed adenocarcinoma of the
colon whowas found to have fever 24 days after aortic aneurysm
surgery; blood cultures revealed Gram-negative bacilli in the
anaerobic bottle, and the organism was identiﬁed as B. virosa by
16S rRNA sequencing. The second case was described by Mehta
et al. [4] in an 81-year-old male veteran who developed fever 18
days after a Whipple procedure for adenocarcinoma of the du-
odenum [4]. Gram-negative bacilli were isolated from the
anaerobic blood culture bottle after 5 days of incubation and
conﬁrmed to be B. virosa by MALDI-TOF MS.
Our patient’s bacteraemia was most likely due to acute
diverticulitis, or inﬂammation of diverticula, which is often
accompanied by gross or microscopic perforation [5]. This is
the presumed source of the B. virosa bacteraemia, as Butyr-
icimonas spp. have previously been isolated from the human
gastrointestinal tract and faeces [6,7]. Given our patient’s
diagnosis of diverticulitis, he later underwent colonoscopy with
biopsy that did not reveal evidence of malignant colonic
neoplasm, although polyps and an adenoma were present.
The only two previously reported cases of human infection
with B. virosa were described in patients with documented
malignancies of the gastrointestinal tract (Table 1). Those pa-
tients were also both male and in the sixth to eighth decade of
life. Fever was noted several weeks after the initial hospitali-
zation. This is in contrast to our patient, who reported sub-
jective fever but did not record his temperature at the time of
his symptoms, so it is not known if he was truly febrile. Two of
the three patients recovered from the infection.© 2016 The Authors. Published by Elsevier Ltd on behal
This is an open access articBefore ﬁnal identiﬁcation of the B. virosa isolate, our patient
was treated with ciproﬂoxacin and metronidazole in order to
provide empiric coverage for typical gastrointestinal ﬂora.
Susceptibility testing of the isolate revealed penicillin and cef-
triaxone resistance, but susceptibility to metronidazole. Toprak
et al. [3] did not provide data on antimicrobial resistance, but
they reported that their isolate was susceptible to penicillin
derivatives, clindamycin and metronidazole (Table 1).
In conclusion, this is only the third reported case of human
infection caused by B. virosa, but the ﬁrst case of B. virosa bac-
teraemia due to diverticulitis and the ﬁrst not associated with a
known gastrointestinal malignancy. Rapidly advancing technol-
ogy such as MALDI-TOF MS is now available to many clinical
laboratories and has provided for expedited and accurate
identiﬁcation of bacteria and other organisms [8]. These ad-
vances have led to the recognition of pathogens such as B. virosa
that were previously considered rare or were not known to
cause human disease [9]. The use of rapid-identiﬁcation systems
such as MALDI-TOF MS continues to provide a broader un-
derstanding of the clinical burden and spectrum of disease
caused by rarely isolated bacteria such as B. virosa and may lead
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